CODX Stock Analysis: Buy, Sell, or Hold?
CODX - Co-Diagnostics, Inc. Common Stock
$3.33
0.21 (6.57%)
▲
5d:
-12.04%
30d:
-10.38%
90d:
+45.83%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When CODX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CODX is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CODX is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CODX is currently trading at $3.33, which is considered slightly low relative to its 30-day fair value range of $2.52 to $7.10.
Technical Outlook: Technically, CODX is in a uptrend. Immediate support is located at $2.95, while resistance sits at $6.55. The stock is showing strong short-term momentum, up 6.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $45.00 (+1342.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CODX is in a uptrend. Immediate support is located at $2.95, while resistance sits at $6.55. The stock is showing strong short-term momentum, up 6.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $45.00 (+1342.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.52 -
$7.10
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.6%)
- BULLISH: Trading 1342.3% below Wall St target ($45.00)
- WARNING: Recommendation downgraded due to -12.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.52 -
$7.10
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.95
Resistance Level
$6.55
Current Trend
Uptrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.26
Wall Street Target
$45.00
(+1342.3%)
Revenue Growth (YoY)
190.3%
Earnings Growth (YoY)
30.8%
Share & Embed Analysis
Last updated: June 23, 2026 11:46 AM ET
Data refreshes hourly during market hours. Next update: 12:46 PM
Data refreshes hourly during market hours. Next update: 12:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CODX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
